Member Info for Silverfoil13

Bailiff .. absolutely right to retain an element of caution and recognise that a golden future for SAR is not absolutely nailed on. All the signs are pointing in the right direction but it’s only when we reach one of the destinations that we will know for sure.
That’s why you need an exit strategy that reflects your personal attitude to risk. My strategy is to achieve a life enhancing return on SAR rather than a life changing result but I am 67 so probably have different ambitions to someone who is say 30 to 40.
So my strategy continues to be to cash in 20% of the declining balance of the number of my shares with every 50% increase in the share price. So for me the next sell threshhold is 11.25p

Thanks Afham .. really appreciate the insight as always .. thank you

Isn’t the comment “Developers of Tyk2 inhibitors will be shifting nervously” concerning or is the Tyk2 product we are working on different .. hence the headline .. “Massive”. Is this likely to prompt a tweet from SAR?

The response to Notalot’s news on this board today has been truly heart warming and revealed a genuine sense of comraderie and proper community spirit on the journey we all taking together with SAR.

Hopefully it has been caught early that is often the key. My sister was diagnosed when 30 at stage 3 and made a full recovery. She was lucky because she had come home for a family wedding and Mum noticed a swollen neck; she was diagnosed and treated immediately. Another few weeks and it might have been too late. During treatment she got a job locally in a self service cafe and took great pleasure from serving people at one end of the counter with her wig on (because of chemo hair loss) and then whipping the wig off and serving them again at the cash till with no hair!! Customers didn’t know what the hell to say!! She had that sense of humour. Hope your treatment goes well and wish you a full recovery.

Interesting looking back to the average price level of 0.0075p around which SAR languished for many years. Current price of around 0.075 represents an increase of 1000% to a market cap of 250 million based largely on potential products in the pipeline. A further increase of 1000% gets us to 75p and a market cap of 2.5 billion but I would have thought we would need some strong clinical evidence of product efficacy to get near this. A 10,000% gain (from 0.0075 to 0.75) doesn’t happen very often and would be fantastic and not beyond the realms of possibility!!

Utah .. at £20 I’d be very confused as totally unknown territory financially .. at 20p I’d just be very happy!!

Big difference .. let’s get to 20.20p that means a second hand Aston Martin Vantage .. £20.02 means a brand new Aston Martin DB11 for every day use (maybe the recently discovered original James Bond DB5??!!) and a Bentley Continental Convertible for touring the vineyards of France!! Dreaming I guess but that’s what you did!!! Let’s get to 20p !! Eminently doable!!

Was that 20.20p or £20.02? If the latter I would have struggled to get back to sleep Nostra!!

Thanks Potnak. Can certainly see 15p to 20p this year as there is so much to be positive about so doubling from where we are now is certainly possible. Hope so because my next 20% sale tranche will be at 11.25p at which point I would have sold roughly half my original holding and quadrupled my initial total investment and have a free run with the rest up to wherever! An incredibly rare opportunity!

I didn’t think was going into the clinic until early 2022? This sounds very encouraging does it suggest things happening a bit earlier than planned?

Thanks James
Glad there are a few of them!!

Do we actually know who the market makers are for SAR? Is there more than one. I guess with a 20% intraday swing in one day they will be gloating through the exit door this evening!!

Just looked at VAL because it has been mentioned a few times looks like LTH have suffered a bit there crikey!! About as bad as my Falklands Oil investments. Why invest in VAL as well as it instead of SAR?

Unlikely the price will drop to 4p unless a bad RNS drops. Last time it was at 4p was 9th June since when we have had 3 HNWI investments, news that 1801 outperforms dexamethasone, the US Patent news and more encouraging news on 737. The perversity of AIM knows no bounds but 4p should be the low base unless really negative news arrived and at 4p most longer term holders are showing gains of 4 to 10 fold. Not life changing gains at that level but certainly worth having.

Reading the recent RNS’s has there actually been much of a delay notified? May 25th 1801 CTA to be filed Q4 clinical trials early 2022, July 1st clinical trials 1801 early 2022, August 19th 1801 CTA to be filed by end of Q4. So all still seems pretty positive to me just maybe a slight drift on time lines. It is only 3 months since the first HNWI invested at 2.9p and 4.9p so he/she will still be happy. The last 2 HNWI who invested in last 5 weeks at 7p and 8.25 will both have had access to latest most up to date information and were still happy to invest. Don’t believe anything in the trading statement would have been unknown to those 2 investors . So I would optimistically put myself in their shoes and if they were happy to stump up a million each then why should we suddenly worry just because SAR has been traded down to just above 6p? The investors investing at 7p and 8.25p will be looking to increase their money manyfold so no reason for us humble LTH to worry

Can anyone with access to level 2 advise the current balance between buys and sells today. It baffles me how a price can be driven down when the trading pattern doesn’t justify it. Is it possible another HNWI subscription is about to be announced at around 7p and our broker is trying to get the market as close to that price as possible before the announcement?

What are these 911 or 991 “trades” people talk about. I know they are both Porsche models but can’t see what they mean in the stock market arena?

Sorry should have read .. Then a short delay has just “sown” a little seed of doubt. The “next” piece of news will shoot the price right up and beyond 9p.

In my view the only thing that is driving this down is the uncertainty created by the slight delay in 1801. Markets hate any form of uncertainty. For 3 months it was one nice bit of news after another building the price up to 9p. Then a short delay has just down a little seed of doubt. The piece of news will shoot the price right up and beyond 9p.